SPONSOR
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Total Trials
2
Recruiting
2
Phases
Phase 3
Karuna Therapeutics, Inc., a Bristol Myers Squibb company is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Schizophrenia, Psychosis Associated With Alzheimer's Disease.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Karuna Therapeutics, Inc., a Bristol Myers Squibb company
How many clinical trials has Karuna Therapeutics, Inc., a Bristol Myers Squibb company sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Karuna Therapeutics, Inc., a Bristol Myers Squibb company, of which 2 are actively recruiting participants. These trials cover conditions including Schizophrenia, Psychosis Associated With Alzheimer's Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Karuna Therapeutics, Inc., a Bristol Myers Squibb company research focus on?
Karuna Therapeutics, Inc., a Bristol Myers Squibb company clinical trials span Schizophrenia, Psychosis Associated With Alzheimer's Disease. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Karuna Therapeutics, Inc., a Bristol Myers Squibb company clinical trial?
To participate in a Karuna Therapeutics, Inc., a Bristol Myers Squibb company trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Karuna Therapeutics, Inc., a Bristol Myers Squibb company trials with current recruitment status updated daily.
Clinical Trials by Karuna Therapeutics, Inc., a Bristol Myers Squibb company
NCT07686263 Phase 3
Recruiting
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Schizophrenia
NCT05511363 Phase 3
Recruiting
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Psychosis Associated With Alzheimer's Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology